MedTrace Logo

Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

NCT00861367 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-03-19

No results posted yet for this study

Summary

Aspirin is very common in older patients. Therefore many of the investigators patients have aspirin. The aim of the study is to proof that Transurethral Surgery of the bladder or the prostate can be performed with aspirin.

Conditions

  • Blood Loss, Surgical
  • Intraoperative Complications
  • Re-operation Rates in Patients With Aspirin Treatment

Interventions

DRUG

transurethral surgery with or without aspirin

aspirin 100mg once a day, transurethral surgery with or without aspirin

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Thomas C Gasser, Prof · Department of Urology, Liestal

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00861367 on ClinicalTrials.gov